Skip to main content
Canada’s most-awarded newsroom for a reason
Enjoy unlimited digital access
$1.99
per week
for 24 weeks
Canada’s most-awarded newsroom for a reason
$1.99
per week
for 24 weeks
// //

A lone star tick is seen under a magnifying glass at a hospital in Southampton, N.Y., on July 6, 2017.

LINDSAY MORRIS/The New York Times News Service

Adding a new weapon to the fight against insect-borne illnesses including Lyme disease and malaria, the Environmental Protection Agency on Monday approved a new chemical that both repels and kills ticks and mosquitoes.

The chemical, nootkatone, an oil found in cedar trees and grapefruits, is so safe that it is used by the food and perfume industries.

Nootkatone is considered nontoxic to humans and other mammals, birds, fish and bees, the EPA said in a statement.

Story continues below advertisement

Diseases caused by the bites of ticks, mosquitoes and fleas have tripled in the United States in the last 15 years, the Centers for Disease Control and Prevention said in a 2018 report. They include Lyme disease, anaplasmosis and Rocky Mountain spotted fever from ticks; West Nile, dengue, Zika and chikungunya from mosquitoes; and plague from fleas.

In tropical countries, malaria and yellow fever are major killers, and elephantiasis is also spread by mosquitoes. Lethal Crimean-Congo hemorrhagic fever is spread by ticks, and kala azar is spread by sandflies.

Manuel F. Lluberas, a public health entomologist who has worked on mosquito-control campaigns around the world, said that he hoped that nootkatone would be accepted by people who fear synthetic repellents and that it could be made cheaply enough to be bought by foreign aid programs like the President’s Malaria Initiative.

The EPA registration applies only to nootkatone as an active ingredient, the statement said. Any formulations using it in the future will have to be tested and registered separately.

The chemical repels mosquitoes, ticks, bedbugs and fleas – and, in high concentrations, kills them, according to the CDC. It may also be effective against lice, sandflies, midges and other pests, some of which can carry lethal diseases.

It is not oily, lasts for hours and has a pleasant, grapefruitlike scent, said Ben Beard, deputy director of the division of vector-borne diseases at the CDC, naming two grapefruit-flavored sodas.

“If you drink Fresca or Squirt, you’ve drunk nootkatone,” Beard said.

Story continues below advertisement

Nootkatone works differently from previous classes of insecticides and can kill bugs that are resistant to DDT, pyrethroids and other common insecticides.

Experts in insect-borne diseases greeted the news with cautious enthusiasm.

“Its use as an insecticidal soap has great potential,” said Duane J. Gubler, a former CDC chief of vector-borne diseases.

One proposed use is in soaps that people in tick-infested areas could shower with, repelling and possibly killing ticks that try to attach to them.

Joel R. Coats, a specialist in insect toxicology at Iowa State University, said his lab had tested nootkatone and found it to be “an impressive repellent but a weak insecticide.”

It repels ticks even better than synthetics like DEET, picaridin or IR3535 do, Coats said, and it is their equal at repelling mosquitoes.

Story continues below advertisement

Unlike citronella, peppermint oil, lemon grass oil and other repellents based on plant oils, he added, nootkatone does not lose its potency after about an hour but lasts as long as the synthetics.

Although it can also kill insects, he said, doing that takes so much of the chemical that it may not be practical.

“Most plant terpenes will kill bugs if you go to a high enough dose, but I haven’t seen any data that supports using it as an insecticide,” Coats said, using a term for aromatic oils exuded by many plants to repel invasive insects. “I’ve seen lots of data on it as a repellent.”

Mikkel Vestergaard-Frandsen, owner of the Vestergaard company, which makes insecticide-impregnated nets to fight malaria, said he was interested in the compound but wanted to know more about it.

Because babies sleep under the nets, any insecticide in them must be safe.

In many areas, mosquitoes have developed resistance to the pyrethin-based insecticides now used in nets, which are synthetic versions of a chemical found in chrysanthemum flowers.

Story continues below advertisement

A version of nootkatone that can linger in netting fabric for years would have to be developed, but good repellents usually dissolve too quickly for that, he said.

The CDC discovered nootkatone’s repellent properties almost 25 years ago as part of a search for new tick-control compounds to fight Lyme disease, Beard said.


They investigated cedar bark and chips “because there are all these folk tales that cedar repels insects – and people keep their clothes in cedar chests,” he said.

Cedar wood itself had very little effect on ticks, he said, but Oregon State University scientists working with the agency found the terpene oil of the Alaskan yellow cedar to be powerfully repellent. The Latin name of the tree is Cupressus nootkatensis, which comes from the Nuu-Chah-Nulth people of Canada.


Story continues below advertisement

It is “not known in great detail” how nootkatone works, Beard said, but it appears to activate octopamine receptors, which in insects send electrical impulses from one nerve cell to the next. Unable to turn off the signal, the bugs twitch to death.

In mammals, adrenaline – which is chemically related to octopamine – performs the same function. But the compound does not trigger adrenaline receptors.

Later the agency realized that the same chemical, originally derived from grapefruit rinds, was used as a flavoring and in perfumes.

The CDC licensed its patent to a Swiss company, Evolva, which isolates the chemical from fermenting yeast.

But doing the safety studies required for EPA registration was too expensive until the 2015-16 Zika epidemic came along, Beard said.

That epidemic prodded Congress to appropriate money for mosquito control, and the CDC transferred some of it to BARDA, the Biomedical Advanced Research and Development Authority, which contracted with Evolva to finish the research.

Story continues below advertisement

Zika funding “was the key to moving the boulder up the hill,” Beard said. But because nootkatone works well on both mosquitoes and ticks, he added, “it wasn’t a bait-and-switch.”

Our Morning Update and Evening Update newsletters are written by Globe editors, giving you a concise summary of the day’s most important headlines. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies